D.E. Shaw & Co’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-20,607
| Closed | -$66K | – | 3695 |
|
|
2021
Q2 | $66K | Sell |
20,607
-25,168
| -55% | -$80.6K | ﹤0.01% | 3392 |
|
|
2021
Q1 | $99K | Sell |
45,775
-5,549
| -11% | -$12K | ﹤0.01% | 2869 |
|
|
2020
Q4 | $115K | Buy |
+51,324
| New | +$115K | ﹤0.01% | 2630 |
|
|
2020
Q3 | – | Sell |
-78,823
| Closed | -$241K | – | 2645 |
|
|
2020
Q2 | $241K | Buy |
+78,823
| New | +$241K | ﹤0.01% | 2401 |
|
|
2020
Q1 | – | Sell |
-19,092
| Closed | -$55K | – | 2726 |
|
|
2019
Q4 | $55K | Buy |
19,092
+6,165
| +48% | +$17.8K | ﹤0.01% | 2588 |
|
|
2019
Q3 | $47K | Sell |
12,927
-6,571
| -34% | -$23.9K | ﹤0.01% | 2483 |
|
|
2019
Q2 | $81K | Buy |
19,498
+3,148
| +19% | +$13.1K | ﹤0.01% | 2501 |
|
|
2019
Q1 | $84K | Buy |
+16,350
| New | +$84K | ﹤0.01% | 2460 |
|
|
2015
Q3 | – | Sell |
-140,753
| Closed | -$384K | – | 2587 |
|
|
2015
Q2 | $384K | Sell |
140,753
-1,117
| -0.8% | -$3.05K | ﹤0.01% | 2251 |
|
|
2015
Q1 | $475K | Buy |
141,870
+66,688
| +89% | +$223K | ﹤0.01% | 2086 |
|
|
2014
Q4 | $261K | Buy |
+75,182
| New | +$261K | ﹤0.01% | 2254 |
|
|
2014
Q3 | – | Sell |
-33,045
| Closed | -$456K | – | 2453 |
|
|
2014
Q2 | $456K | Buy |
+33,045
| New | +$456K | ﹤0.01% | 1929 |
|